Search filters

List of works by Marie Vétizou

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

scientific article published on 5 November 2015

Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.

scientific article

Cancer and the gut microbiota: an unexpected link

scientific article published on January 2015

Cell-death-associated molecular patterns as determinants of cancer immunogenicity

scientific article published on 20 March 2013

Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.

scientific article

Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines

scientific article published on 07 June 2013

Enhancing the clinical coverage and anticancer efficacy of immune checkpoint blockade through manipulation of the gut microbiota

scientific article published on 18 February 2016

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

scientific article

Erratum: anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.

scientific article published in March 2015

Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells

scientific article published on 10 September 2015

Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome

scientific article

Gut microbiota and efficacy of cancer therapies

scientific article published on 6 July 2017

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

scientific article

Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors

scientific article published on June 2016

Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade

scientific article published on 03 September 2019

The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade

scientific article published on 15 April 2016

The role of intestinal microbiota in the response to anti-tumor therapies

scientific article